Histone Therapeutics
- Biotech or pharma, therapeutic R&D
Histone Therapeutics (Histone Tx) is a Seattle-based biotech company developing novel epigenetic editing technologies to treat disease by directly controlling gene regulation. Its first-in-class modulator proteins restore or amplify gene expression in ways other modalities cannot. Using lipid nanoparticle-encoded mRNA, Histone Tx precisely enhances gene expression in hard-to-target tissues without relying on enzymes that cause off-target effects. The team is driven by the conviction that gene up-regulation offers new therapeutic possibilities to enhance human health.